Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,623,309
  • Shares Outstanding, K 135,213
  • Annual Sales, $ 443,310 K
  • Annual Income, $ 402,710 K
  • 60-Month Beta 1.26
  • Price/Sales 17.06
  • Price/Cash Flow 27.90
  • Price/Book 79.46
Trade HALO with:

Options Overview Details

View History
  • Implied Volatility 35.62% ( +4.04%)
  • Historical Volatility 39.90%
  • IV Percentile 6%
  • IV Rank 17.37%
  • IV High 75.14% on 01/26/22
  • IV Low 27.30% on 12/15/21
  • Put/Call Vol Ratio 0.04
  • Today's Volume 334
  • Volume Avg (30-Day) 349
  • Put/Call OI Ratio 0.41
  • Today's Open Interest 11,493
  • Open Int (30-Day) 11,134

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.43
  • Number of Estimates 5
  • High Estimate 0.49
  • Low Estimate 0.40
  • Prior Year 0.39
  • Growth Rate Est. (year over year) +10.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.21 +27.72%
on 11/08/22
59.46 -2.89%
on 12/02/22
+11.46 (+24.76%)
since 11/07/22
3-Month
38.03 +51.83%
on 09/23/22
59.46 -2.89%
on 12/02/22
+18.33 (+46.51%)
since 09/07/22
52-Week
31.36 +84.12%
on 01/28/22
59.46 -2.89%
on 12/02/22
+25.39 (+78.49%)
since 12/07/21

Most Recent Stories

More News
Halozyme (HALO) Stock Rises 35% in the Year so Far: Here's Why

Halozyme (HALO) is gaining on its proprietary drug delivery technology, ENHANZE. It expects strong revenues on the back of robust demand for its new partnered drugs.

RHHBY : 39.9500 (-0.79%)
JNJ : 177.17 (+0.61%)
HALO : 57.74 (+2.41%)
ARGX : 384.37 (-0.30%)
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

HALO : 57.74 (+2.41%)
GILD vs. HALO: Which Stock Is the Better Value Option?

GILD vs. HALO: Which Stock Is the Better Value Option?

GILD : 87.79 (-0.19%)
HALO : 57.74 (+2.41%)
Halo Collective Reports Highest Selling Quarter for Budega Retail Locations and Plans to Continue Expansion

/PRNewswire/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) reports highest selling quarter and continues planned...

AKAN : 0.1950 (+2.47%)
HALO : 57.74 (+2.41%)
HCANF : 0.0570 (-10.38%)
Halo Collective Reports Highest Selling Quarter for Budega Retail Locations and Plans to Continue Expansion

/CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) reports highest selling quarter and continues planned...

HALO : 57.74 (+2.41%)
HCANF : 0.0570 (-10.38%)
Halo Collective Reports Third Quarter 2022 Financial Results

/CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announces its financial and operational results for the...

HALO : 57.74 (+2.41%)
HCANF : 0.0570 (-10.38%)
Halo Collective Enters into Convertible Promissory Note for Aggregate Principal Amount of Up To C$5 Million

/CNW/ - Halo Collective Inc. ("Halo" or the "Company") (NEO: HALO) (OTCQB: HCANF) (Germany: A9KN) today announced that it has entered into a promissory note...

HALO : 57.74 (+2.41%)
HCANF : 0.0570 (-10.38%)
Halozyme's (HALO) Q3 Earnings and Revenues Surpass Estimates

Halozyme's (HALO) earnings and revenues beat estimates for the third quarter of 2022.

RHHBY : 39.9500 (-0.79%)
JNJ : 177.17 (+0.61%)
HALO : 57.74 (+2.41%)
ASLN : 0.5040 (-2.76%)
Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates

Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 42.31% and 11.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

HALO : 57.74 (+2.41%)
HUMA : 2.97 (-1.66%)
Halozyme Therapeutics: Q3 Earnings Snapshot

Halozyme Therapeutics: Q3 Earnings Snapshot

HALO : 57.74 (+2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Halozyme Therapeutics Inc. is a biopharmaceutical company, focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment. The company's ENHANZE drug delivery technology helps in developing subcutaneous formulation of drugs. The company...

See More

Key Turning Points

3rd Resistance Point 60.00
2nd Resistance Point 58.90
1st Resistance Point 58.32
Last Price 57.74
1st Support Level 56.64
2nd Support Level 55.54
3rd Support Level 54.96

See More

52-Week High 59.46
Last Price 57.74
Fibonacci 61.8% 48.73
Fibonacci 50% 45.41
Fibonacci 38.2% 42.09
52-Week Low 31.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar